文献速递神经肿瘤

大鼠原位胶质母细胞瘤模型中MRI监测激光间质热疗的适应性研究

Adaptation of laser interstitial thermal therapy for tumor ablation under MRI monitoring in a rat orthotopic model of glioblastoma.
PubMed 文献 · Acta Neurochir (Wien) · 2021-09-23

本研究在大鼠U251胶质母细胞瘤原位模型中适应性开展MRI监测下的激光间质热疗(LITT)。5只大鼠在DWI-MRI引导下进行消融,3只未治疗作为对照。结果显示LITT可实现肿瘤近完全消融,边界清晰,24小时消融周可见对比增强,组织病理学(H&E和MHC染色)证实了MRI所见的肿瘤减容效果。

要点

  • MRI监测下LITT在大鼠胶质瘤模型中可行,能实现近完全肿瘤消融。
  • 消融后24小时MRI显示边界清晰的消融区伴周边对比增强。
  • 组织病理学(H&E和MHC染色)证实了MRI所见的肿瘤细胞减灭效果。

核心结论

  • 在临床前胶质瘤模型中,MRI监测下LITT进行肿瘤细胞消融是可行的。
  • 实时MRI监测有助于可视化和控制消融区域,与临床应用方式一致。

研究设计与样本

  • 采用大鼠U251胶质母细胞瘤(GBM)原位模型。
  • 通过MRI和动态对比增强(DCE)MRI确定肿瘤位置和范围。
  • LITT组(n=5)在DWI-MRI引导下使用Visualase LITT系统进行消融,对照组(n=3)未治疗。
  • 消融后即刻及24小时行脑部MRI确认消融效果,随后注射FITC右旋糖酐和伊文思蓝循环10分钟后取脑行荧光显微镜及H&E和MHC染色组织病理学评估。

主要发现

  • 所有大鼠在LITT前MRI均显示占位性肿瘤伴T2和T1对比增强。
  • LITT组大鼠显示边界清晰的消融区,肿瘤组织近完全消融,消融后24小时可见消融周对比增强。
  • H&E和MHC染色证实了MRI所见的肿瘤细胞减灭效果。

临床怎么用

  • 该临床前模型支持MRI监测下LITT作为胶质瘤细胞减灭手段的可行性。
  • 实时MRI监测可辅助可视化及控制消融范围,与临床操作一致。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Laser interstitial thermal therapy (LITT) under magnetic resonance imaging (MRI) monitoring is being increasingly used in cytoreductive surgery of recurrent brain tumors and tumors located in eloquent brain areas. The objective of this study was to adapt this technique to an animal glioma model. METHODS: A rat model of U251 glioblastoma (GBM) was employed. Tumor location and extent were determined by MRI and dynamic contrast-enhanced (DCE) MRI. A day after assessing tumor appearance, tumors were ablated during diffusion-weighted imaging (DWI)-MRI using a Visualase LITT system (n = 5). Brain images were obtained immediately after ablation and again at 24 h post-ablation to confirm the efficacy of tumor cytoablation. Untreated tumors served as controls (n = 3). Rats were injected with fluorescent isothiocyanate (FITC) dextran and Evans blue that circulated for 10 min after post-LITT MRI. The brains were then removed for fluorescence microscopy and histopathology evaluations using hematoxylin and eosin (H&E) and major histocompatibility complex (MHC) staining. RESULTS: All rats showed a space-occupying tumor with T2 and T1 contrast-enhancement at pre-LITT imaging. The rats that underwent the LITT procedure showed a well-demarcated ablation zone with near-complete ablation of tumor tissue and with peri-ablation contrast enhancement at 24 h post-ablation. Tumor cytoreduction by ablation as seen on MRI was confirmed by H&E and MHC staining. CONCLUSIONS: Data showed that tumor cytoablation using MRI-monitored LITT was possible in preclinical glioma models. Real-time MRI monitoring facilitated visualizing and controlling the area of ablation as it is otherwise performed in clinical applications.

来源:Acta Neurochir (Wien),查看原文。版权归原作者所有。

引用

  1. Nagaraja TN, Bartlett S, Farmer KG, et al. Adaptation of laser interstitial thermal therapy for tumor ablation under MRI monitoring in a rat orthotopic model of glioblastoma. Acta Neurochir (Wien). 2021. PMID: 34554269. doi:10.1007/s00701-021-05002-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。